Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, & Xiang-Shuo Kong. (2023). A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014-2022). Frontiers Media S.A..
Chicago Style (17th ed.) CitationCong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, and Xiang-Shuo Kong. A Bibliometric Study on the Utilization of Lenvatinib in Hepatocellular Carcinoma (2014-2022). Frontiers Media S.A., 2023.
MLA (9th ed.) CitationCong-Cong Wang, et al. A Bibliometric Study on the Utilization of Lenvatinib in Hepatocellular Carcinoma (2014-2022). Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.